End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.017 AUD | -5.56% | +13.33% | -15.00% |
04-30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
04-10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.00% | 14.19M | |
+30.03% | 684B | |
+30.34% | 568B | |
-3.94% | 361B | |
+18.09% | 329B | |
+4.14% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.83% | 166B |
- Stock Market
- Equities
- SNT Stock
- News Syntara Limited
- Australian Bourse Halts Trading in Pharmaxis’ Securities